Mirae Asset Global Etfs Holdings Ltd. Intellia Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 211,367 shares of NTLA stock, worth $3.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
211,367
Previous 234,815
9.99%
Holding current value
$3.3 Million
Previous $5.26 Million
17.35%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding NTLA
# of Institutions
315Shares Held
91.5MCall Options Held
442KPut Options Held
880K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.3MShares$191 Million2.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.63MShares$150 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$150 Million0.0% of portfolio
-
State Street Corp Boston, MA5.14MShares$80.3 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.95MShares$77.3 Million3.75% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.19B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...